Worth reading
61In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
1400000
¥Wording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance of the 12th Stock Acquisition Rights (with Exercise Price Adjustment Clause) through a Third-Party Allotment
Who receives how much
Number of potential shares: 10,000,000 shares (100,000 Stock Acquisition Rights, with 100 shares per Stock Acquisition Right)
EVO FUND: 100,000 Stock Acquisition Rights
The lower thin line represents the existing number of shares to which these shares will be added.
¥14 per Stock Acquisition Right
Total issue value
¥1,400,000
Amount of funds to be raised
¥1,271,400,000 (estimated net proceeds after deducting expenses: ¥1,246,400,000)
Estimated issuance expenses
¥25,000,000
Terms of the stock acquisition rights
Exercise price
Initial exercise price: ¥127. Exercise price adjustment clause applies. Minimum exercise price: ¥64.
Exercise period
From 10 August 2026 to 10 August 2028
Number of Stock Acquisition Rights
Total issuance: 100,000 warrants. Number of warrants outstanding and unexercised: Not disclosed.
Reason for acquisition without consideration
After one month has elapsed from the payment date, the Company may acquire all or part of the remaining Stock Acquisition Rights if it resolves that their acquisition is necessary and gives notice at least 2 weeks before the acquisition date. The Company will also acquire all Stock Acquisition Rights remaining at the end of the exercise period.
Payment date
7 August 2026
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of the 12th Stock Acquisition Rights (with Exercise Price Adjustment Clause) through a Third-Party Allotment |
| Number of shares to be issued or disposed of | Number of potential shares: 10,000,000 shares (100,000 Stock Acquisition Rights, with 100 shares per Stock Acquisition Right) |
| Issue price and disposal price | ¥14 per Stock Acquisition Right |
| Total issue value | ¥1,400,000 |
| Amount of funds to be raised | ¥1,271,400,000 (estimated net proceeds after deducting expenses: ¥1,246,400,000) |
| Estimated issuance expenses | ¥25,000,000 |
| Payment date | 7 August 2026 |
| Intended allottee | EVO FUND: 100,000 Stock Acquisition Rights |
| Exercise price | Initial exercise price: ¥127. Exercise price adjustment clause applies. Minimum exercise price: ¥64. |
| Exercise period | From 10 August 2026 to 10 August 2028 |
| Number of Stock Acquisition Rights | Total issuance: 100,000 warrants. Number of warrants outstanding and unexercised: Not disclosed. |
| Reason for acquisition without consideration | After one month has elapsed from the payment date, the Company may acquire all or part of the remaining Stock Acquisition Rights if it resolves that their acquisition is necessary and gives notice at least 2 weeks before the acquisition date. The Company will also acquire all Stock Acquisition Rights remaining at the end of the exercise period. |
Items this document does not state (16)
Specific use of fundsIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidTransfer restriction periodConditions for lifting transfer restrictionsCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Payment of the total issue price for the issuance of these Stock Acquisition Rights, as resolved at the Board of Directors meeting held on 22 July 2026, was completed on 7 August 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.